Transderm Scop

Clinically proven to prevent motion sickness
Ear with Patch
Easy to Use
Info for Patients
Info for Doctors


  • Clinically proven to prevent motion sickness

  • In clinical studies, 5 out of 6 people did not report drowsiness with Transderm Scop®.1

  • Long Lasting
    One Transderm Scop® patch lasts up to 3 days.

    1 Transderm Scop® is not for children or those with glaucoma, difficulty in urinating, or an allergy to scopolamine or other belladonna alkaloids. In clinical studies, some side effects were noted, including blurred vision, dryness of the mouth (in two-thirds of users) and drowsiness (reported incidence less than 1 in 6). While using this product, you should not drive, operate dangerous machinery or do other things that require alertness. Avoid using alcohol. If you are elderly, your physician should exercise special care in prescribing this product. Click here for additional information on potential adverse reactions or side effects.

    Copyright 2004 © Novartis Consumer Health Inc. All Rights Reserved. Your use of this website is subject to the terms of our Legal Statement and Privacy Policy. The product information contained in this site is intended for residents of the United States only. For more information on Novartis and other Novartis products, see Novartis.com.

    Novartis

    Last Updated: Monday, March 21, 2005